In a mouse model of malaria, we tested R21 with two liposomal adjuvants (LQ, LMQ) and two squalene emulsion adjuvants (SQ, SMQ), all containing saponin QS-21, and LMQ and SMQ additionally supplemented with a synthetic MPL-like TLR4 agonist. The gene discussed is TLR4; the disease is malaria.